Table 3. Final multivariable models, following backward elimination of non-significant (P >0.05) variables, for which the outcome variables were the proportion of cases showing erythema migrans, neurological manifestations and cardiac manifestations.
Variable | Odds ratio | 95% Confidence interval | Wald z | P value |
---|---|---|---|---|
Outcome = erythema migrans | ||||
Year 2010 versus 2009 | 1.364 | 0.616-3.018 | 0.77 | >0.1 |
Year 2011 versus 2009 | 2.232 | 1.109-4.489 | 2.25 | <0.05 |
Year 2012 versus 2009 | 2.860 | 1.416-5.778 | 2.93 | <0.01 |
Age | 1.015 | 1.004-1.027 | 2.71 | <0.01 |
Outcome = neurological manifestations | ||||
Women versus men | 0.561 | 0.345-0.940 | -2.19 | <0.05 |
Age | 1.073 | 1.014-1.146 | 2.45 | <0.05 |
Age squared | 0.998 | 0.998-0.999 | -0.30 | <0.01 |
Ontario versus New Brunswick and Nova Scotia | 3.781 | 1.849-7.772 | 3.62 | <0.001 |
Outcome = cardiac manifestations | ||||
Age | 1.305 | 1.043-1.632 | 2.33 | <0.05 |
Age squared | 0.997 | 0.994-0.999 | -2.41 | <0.05 |